Researchers at Cedars-Sinai, led by Dr. Alan C. Kwan, have developed an AI algorithm that can detect chronic liver disease—such as steatosis and cirrhosis—using standard transthoracic echocardiogram (TTE) videos. The tool analyzes subcostal views from heart ultrasounds, which incidentally capture images of the liver, and predicts liver disease with notable accuracy.
Author: Rutali Thakur
Sam Holliday, CEO and Co-Founder of Oshi Health, is leading the transformation of gastrointestinal (GI) care through a virtual, multidisciplinary approach. Motivated by personal experiences with his family’s GI health challenges, Holliday established Oshi Health in 2019 to address the shortcomings of traditional GI care. The company offers integrated services—including medical care, dietary guidance, and behavioral health support—through a virtual platform, aiming to improve patient outcomes and reduce healthcare costs. Oshi Health’s model has demonstrated significant success: Under Holliday’s leadership, Oshi Health has expanded its services nationwide, partnering with health plans and employers to provide accessible, high-quality GI care. The…
The microbiome—a vast ecosystem of microbes within our bodies—is emerging as a foundational platform for health, influencing everything from immunity and digestion to mental health and drug response. Despite growing scientific evidence, the healthcare industry often treats it as a niche trend, limiting its potential. The article argues for a paradigm shift: to stop viewing the microbiome as a wellness product and start integrating it into diagnostics, chronic care, and personalized medicine. The future of healthcare, it suggests, may depend not on external innovation, but on unlocking the power of the microscopic world within us.
The U.S. Food and Drug Administration (FDA) and Novo Nordisk are warning people not to use counterfeit semaglutide 1.0 mg (Ozempic injection) found in the US drug supply chain. Novo Nordisk notified the FDA on April 3, 2025 that several hundred units of the fake product had been distributed outside the company’s authorized supply chain. The FDA seized the identified products on April 9, 2025, but some may still be circulating. Patients, wholesalers, retail pharmacies, and healthcare professionals are advised to check Ozempic boxes for the lot number PAR0362 and serial number beginning with the first eight digits, 51746517. The lot number is legitimate,…
CMR Surgical has raised over $200 million in equity and debt to accelerate the global rollout of its Versius Surgical Robotic System, which has already completed more than 30,000 procedures in 30+ countries. The funding round, backed by existing investors and Trinity Capital, underscores growing confidence in CMR’s minimally invasive technology and U.K. life sciences sector. With a compact, modular design and advanced ergonomic features, Versius is gaining traction across multiple specialties and is now the world’s second most-used soft-tissue surgical robot. As CMR eyes U.S. expansion and new clinical trials—including pediatric and transoral surgeries—it’s not just building robots; it’s…
Medicare physician reimbursement could reflect inflation under a new formula recommended by the Medicare Payment Advisory Commission (MedPAC). On April 10, MedPAC members voted unanimously to send Congress two draft recommendations that have been in discussion for months. They are:
Don’t miss this year’s plenary on Monday, May 5, featuring futurist Praveen Suthrum speaking on Future Innovation in GI.
Key takeaways: Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in JAMA Surgery.
AGA has partnered with Beyond Celiac, the leading nonprofit organization dedicated to finding a cure for celiac disease, to establish the AGA–Beyond Celiac Pilot Research Award in Celiac Disease. The one-year $40,000 grant will support independent scientists at any career stage who are researching new directions in celiac disease and gluten-related disorders. The grant will be funded by Beyond Celiac and managed by the AGA Research Foundation.
A tiny magnetic robot which can take 3D scans from deep within the body, that could revolutionise early cancer detection, has been developed by researchers. The team, led by engineers from the University of Leeds, say this is the first time it has been possible to generate high-resolution three-dimensional ultrasound images taken from a probe deep inside the gastrointestinal tract, or gut. It paves the way to a transformation of the diagnosis and treatment of several forms of cancer by enabling ‘virtual biopsies’ — non-invasive scans that provide immediate diagnostic data, allowing doctors to detect, stage, and potentially treat lesions…